Factors associated with prevalent hypertension among adults living with HIV receiving antiretroviral therapy in Yaounde, Cameroon: a cross-sectional study Authors: Francis Duhamel Nang Nang, Liliane Mfeukeu Kuate, Paul Junior Chebo, Anastase Dzudie, Luc Baudoin Fankoua Tchaptcha, Andre Pascal Kengne, Jean Pierre Junior Tchitetchoun, Francois Anicet Onana Akoa, Rita Marie Ifoue, Lawson Ngwagwe Mbolueh, Charles Kouanfack, Simeon Pierre Choukem Published: 2026 ABSTRACT AbstractBackgroundHypertension is a frequent comorbidity among people living with HIV (PLHIV) in sub-Saharan Africa, but analytical data from routine HIV clinics in Cameroon remain limited. This study assessed factors associated with prevalent hypertension among adults receiving antiretroviral therapy (ART) at an urban HIV clinic in Yaounde, Cameroon.MethodsWe conducted a cross-sectional study at the Day Hospital of Yaounde Central Hospital between January and March 2024. The analytical dataset included 460 adults living with HIV receiving ART. Prevalent hypertension was coded as a binary outcome. Robust Poisson regression was used to estimate prevalence ratios (PRs) and adjusted prevalence ratios (aPRs) because hypertension was common. Sensitivity models were fitted to clarify the interpretation of cumulative ART duration in relation to current age.ResultsAmong 460 participants, 199 (43.3%) had prevalent hypertension. The mean age was 50.5 ± 10.9 years, and 338 (73.5%) participants were women. In bivariable analysis, older age (PR per 1-year increase 1.02, 95% CI 1.01–1.03; p < 0.001), longer ART duration (PR per 1-year increase 1.03, 95% CI 1.01–1.05; p < 0.001), family history of hypertension (PR 2.98, 95% CI 2.40–3.71; p < 0.001), HIV stage II at ART initiation (PR 1.29, 95% CI 1.03–1.60; p = 0.024), and obesity (PR 1.43, 95% CI 1.10–1.87; p = 0.007) were associated with hypertension. In the final multivariable model, older age (aPR 1.02, 95% CI 1.01–1.03; p = 0.002), family history of hypertension (aPR 2.83, 95% CI 2.25–3.57; p < 0.001), and obesity (aPR 1.29, 95% CI 1.01–1.65; p = 0.045) remained independently associated with prevalent hypertension, whereas cumulative ART duration was not independently associated after adjustment (aPR 1.00, 95% CI 0.99–1.02; p = 0.619). Restricted cubic spline analysis did not show evidence of an overall association or non-linearity for ART duration.ConclusionsIn this urban HIV clinic, hypertension was frequent and was associated mainly with age, family history of hypertension, and obesity in the adjusted model. Cumulative ART duration was associated with hypertension in crude or minimally adjusted models but not after adjustment for age and cardiometabolic factors. These findings support integrating routine blood-pressure screening, weight management, lifestyle counselling, and standardized hypertension care into HIV services.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12981-026-00905-1.Keywords: HIV infections, Hypertension, Antiretroviral therapy, Prevalence ratio, Cross-sectional study, Cameroon Introduction With expanded access to antiretroviral therapy (ART), HIV infection has increasingly become a chronic condition, and non-communicable diseases are now an important component of long-term morbidity among people living with HIV (PLHIV). Hypertension is a major contributor to cardiovascular disease and premature mortality, and its prevention is increasingly relevant to HIV programmes in sub-Saharan Africa [1–5]. PLHIV may experience a higher burden of hypertension than the general population through a combination of ageing, chronic inflammation, endothelial dysfunction, adiposity, and conventional lifestyle-related cardiometabolic risks. Some studies have also examined whether cumulative ART exposure, specific drug classes, or treatment switches may contribute to blood pressure elevation, but findings have been inconsistent across settings [2, 6–12]. In Cameroon, hypertension has been reported frequently among PLHIV in routine care, including in Yaounde, with substantial gaps in detection, treatment, and control [2, 3, 6, 7]. However, limited analytical work from urban HIV clinics has examined cumulative ART duration alongside conventional cardiometabolic and behavioural factors in the same model. Clarifying these associations is important for integrated HIV-non-communicable disease care and for implementation of standardized cardiovascular prevention approaches such as WHO HEARTS [13, 14]. The present study aimed to identify factors associated with prevalent hypertension among adults living with HIV receiving ART at Yaounde Central Hospital. Cumulative ART duration was examined as the main explanatory variable of interest alongside age, adiposity, family history of hypertension, and lifestyle-related factors. Materials and methods Study design and setting We conducted a cross-sectional study at the Day Hospital of Yaounde Central Hospital, Cameroon, between January and March 2024. The clinic is a large urban HIV care centre serving approximately 12,000 PLHIV. All measurements and record abstractions were obtained at a single point in time for each participant. Reporting was revised with reference to STROBE guidance for cross-sectional studies [15]. Participants and eligibility Eligible participants were adults aged 21 years or older, living with HIV, followed at the clinic for at least 6 months, and with available information on blood pressure and ART history at the index visit. Pre-enrolment non-inclusion criteria were pregnancy, hypertensive emergency at presentation, chronic renal dialysis, age below 21 years, and follow-up shorter than 6 months. The final analytical dataset contained 460 participants with non-missing hypertension status, age, and ART duration. Sampling Participants were recruited through consecutive convenience sampling during routine follow-up visits. This approach was chosen for operational feasibility within the study period and may limit representativeness beyond this clinic population. Outcome definition The outcome was prevalent hypertension at the index visit, coded as a binary variable. Hypertension was defined using the study blood-pressure classification and available clinical information. Because elevated blood pressure observed during a cross-sectional visit may include both established and potentially transient blood-pressure elevation, the outcome is interpreted as prevalent hypertension rather than incident hypertension. Exposure and covariates The primary exposure was cumulative ART duration in years, analysed mainly as a continuous variable. Candidate covariates included age, sex, marital status, education, employment, family history of hypertension, BMI category, HIV stage at ART initiation, ART treatment line, viral-load status, salt/seasoning cube intake, fruit and vegetable intake, physical activity, tobacco use, and alcohol use. Viral-load categories were simplified to avoid conceptual overlap between undetectable and suppressed categories. Blood pressure, anthropometry, and routine clinical measurements Blood pressure was measured with a validated automated oscillometric device using three seated readings taken 1–2 min apart after a rest period; the mean of the last two readings was used for classification. Weight and height were measured using standard procedures and used to compute body mass index (BMI), categorized as normal weight, overweight, and obesity. Sociodemographic, HIV treatment history, and pharmacy information were abstracted from routine clinic records using a standardized case-report form. Dietary and behavioural variables Salt/seasoning cube intake, fruit and vegetable intake, physical activity, tobacco use, and alcohol use were based on routine questionnaire data. Dietary and behavioural variables are interpreted cautiously as self-reported proxies because their cross-sectional measurement can be affected by recall, social desirability, and reverse causation. Statistical analysis Continuous variables were summarized as mean ± standard deviation, and categorical variables as counts and percentages. Missingness was tabulated for variables considered in descriptive, bivariable, multivariable, and sensitivity analyses. Robust Poisson regression was used to estimate crude and adjusted prevalence ratios (PRs and aPRs) with 95% confidence intervals because hypertension was a common cross-sectional outcome and prevalence ratios were more interpretable than odds ratios. Variables with p-values below 0.20 in bivariable analyses were considered eligible for multivariable modelling. Age and ART duration were retained a priori because of their clinical and epidemiological relevance. Several sensitivity models were fitted to clarify the interpretation of ART duration in relation to current age and estimated age at ART initiation. Restricted cubic spline analysis was used to display adjusted predicted probabilities of hypertension across ART duration; the visualization model adjusted for age, family history of hypertension, BMI category, and fruit and vegetable intake. Ethics The study was approved by the Regional Ethics Committee for Human Health Research in the Centre Region of Cameroon (CRERSHC No. CEN000633/CRERSHC/2023, 8 August 2023). Administrative authorization was granted by the Director of Yaounde Central Hospital (No. 2023/265/AR/MINSANTE/SG/DHCY/UAF, 8 May 2023). All participants provided written informed consent. Results Participant flow and missing data The analytical dataset contained 460 records. Hypertension status, age, estimated age at ART initiation, ART duration, sex, sociodemographic variables, clinical variables, viral-load status, dietary variables, tobacco use, and alcohol use were complete. Physical activity had three missing values (0.7%). Complete-case analyses for the main multivariable model included 460 participants. Descriptive characteristics Among 460 adults living with HIV receiving ART, 199 (43.3%) had prevalent hypertension and 261 (56.7%) were non-hypertensive. The mean age was 50.5 ±10.9 years overall, 53.1 ±10.1 years among hypertensive participants, and 48.5 ± 11.0 years among non-hypertensive participants. Women represented 338 (73.5%) participants. The mean cumulative ART duration was 10.9 ± 5.9 years overall, 12.1 ± 5.5 years among hypertensive participants, and 10.1 ± 6.1 years among non-hypertensive participants (Table 1). Table 1Sociodemographic, clinical, and treatment characteristics of the study population stratified by hypertension statusVariableCategoryOverallHypertensiveNon-hypertensiveAge (years)Mean ± SD50.5 ± 10.953.1 ± 10.148.5 ± 11.0SexFemale338 (73.5%)142 (71.4%)196 (75.1%)Male122 (26.5%)57 (28.6%)65 (24.9%)Marital statusCohabiting58 (12.6%)20 (10.1%)38 (14.6%)Divorced13 (2.8%)4 (2.0%)9 (3.4%)Married180 (39.1%)86 (43.2%)94 (36.0%)Single122 (26.5%)46 (23.1%)76 (29.1%)Widowed87 (18.9%)43 (21.6%)44 (16.9%)Education levelHigher49 (10.7%)19 (9.5%)30 (11.5%)None23 (5.0%)14 (7.0%)9 (3.4%)Primary133 (28.9%)64 (32.2%)69 (26.4%)Secondary255 (55.4%)102 (51.3%)153 (58.6%)Employment statusEmployed97 (21.1%)32 (16.1%)65 (24.9%)Retired72 (15.7%)37 (18.6%)35 (13.4%)Self-employed137 (29.8%)55 (27.6%)82 (31.4%)Unemployed154 (33.5%)75 (37.7%)79 (30.3%)Family history of hypertensionNo289 (62.8%)72 (36.2%)217 (83.1%)Yes171 (37.2%)127 (63.8%)44 (16.9%)HIV stage at initiationI235 (51.1%)93 (46.7%)142 (54.4%)II159 (34.6%)81 (40.7%)78 (29.9%)III/IV66 (14.3%)25 (12.6%)41 (15.7%)BMI categoryNormal weight188 (40.9%)68 (34.2%)120 (46.0%)Obesity106 (23.0%)55 (27.6%)51 (19.5%)Overweight166 (36.1%)76 (38.2%)90 (34.5%)ART treatment lineFirst-line376 (81.7%)157 (78.9%)219 (83.9%)Second/third-line84 (18.3%)42 (21.1%)42 (16.1%)Viral load statusHigh/unsuppressed50 (10.9%)20 (10.1%)30 (11.5%)Suppressed/undetectable410 (89.1%)179 (89.9%)231 (88.5%)ART duration (years)Mean ± SD10.9 ± 5.912.1 ± 5.510.1 ± 6.1Salt/seasoning cube intakeNo186 (40.4%)91 (45.7%)95 (36.4%)Yes274 (59.6%)108 (54.3%)166 (63.6%)Fruit and vegetable intakeOnce per week242 (52.6%)101 (50.8%)141 (54.0%)Rarely90 (19.6%)35 (17.6%)55 (21.1%)Three times per week49 (10.7%)18 (9.0%)31 (11.9%)Twice per week79 (17.2%)45 (22.6%)34 (13.0%)ART antiretroviral therapy, BMI body mass indexPercentages are column percentages unless otherwise specified Sociodemographic, clinical, and treatment characteristics of the study population stratified by hypertension status ART antiretroviral therapy, BMI body mass index Percentages are column percentages unless otherwise specified Bivariable analyses In bivariable robust Poisson models, older age, longer cumulative ART duration, family history of hypertension, HIV stage II at ART initiation, obesity, unemployment, retirement, no formal education, and some dietary categories were associated with prevalent hypertension. ART treatment line and viral-load status were not significantly associated with hypertension in bivariable analyses (Table 2). Table 2Bivariable analysis of factors associated with hypertension among adults receiving antiretroviral therapyVariableCategoryPR95% CIp-valueAge (years)Per 1-year increase1.021.01–1.03< 0.001SexFemale (ref)1.00––Male1.110.89–1.400.359Marital statusMarried (ref)1.00––Single0.790.60–1.040.091Cohabiting0.720.49–1.060.098Divorced0.640.28–1.480.298Widowed1.030.80–1.340.800Education levelSecondary (ref)1.00––None1.521.06–2.180.022Primary1.200.95–1.520.118Higher0.970.66–1.420.873Employment statusEmployed (ref)1.00––Self-employed1.220.86–1.730.271Unemployed1.481.06–2.050.019Retired1.561.08–2.240.016Family history of hypertensionNo (ref)1.00––Yes2.982.40–3.71< 0.001HIV stage at initiationI (ref)1.00––II1.291.03–1.600.024III/IV0.960.68–1.350.805BMI categoryNormal weight (ref)1.00––Obesity1.431.10–1.870.007Overweight1.270.98–1.630.067ART treatment lineFirst-line (ref)1.00––Second/third-line1.200.94–1.530.149Viral load statusSuppressed/undetectable (ref)1.00––High/unsuppressed0.920.64–1.310.631ART duration (years)Per 1-year increase1.031.01–1.05< 0.001Salt/seasoning cube intakeNo (ref)1.00––Yes0.810.65–0.990.041Fruit and vegetable intakeTwice per week (ref)1.00––Once per week0.730.57–0.930.012Rarely0.680.49–0.940.020Three times per week0.640.43–0.980.038Physical activityAdequate (WHO-compliant) (ref)1.00––High/optimal1.000.61–1.640.997Low1.140.73–1.780.559Monthly frequency (once/month)1.460.86–2.490.160Inactive1.110.74–1.670.607Tobacco useNo (ref)1.00––Yes0.800.57–1.130.208Alcohol useWeekly/daily (ref)1.00––Monthly1.030.72–1.490.856None1.010.76–1.340.935Occasional1.000.76–1.320.984PR prevalence ratio, CI confidence intervalAll estimates are crude prevalence ratios from robust Poisson regression Bivariable analysis of factors associated with hypertension among adults receiving antiretroviral therapy PR prevalence ratio, CI confidence interval All estimates are crude prevalence ratios from robust Poisson regression Variable selection and model-building strategy Variables with p-values below 0.20 in bivariable analyses were considered eligible for multivariable modelling. Age and ART duration were retained a priori because of their clinical and epidemiological relevance. A corrected viral-load variable was used to avoid overlapping categories between undetectable and suppressed viral load. Some variables eligible at bivariable screening were not retained in the final parsimonious model. Multivariable analysis In the final multivariable model, older age remained independently associated with prevalent hypertension (aPR per 1-year increase 1.02, 95% CI 1.01–1.03; p = 0.002). Family history of hypertension showed the strongest independent association (aPR 2.83, 95% CI 2.25–3.57; p < 0.001). Obesity was independently associated with hypertension (aPR 1.29, 95% CI 1.01–1.65; p = 0.045), while overweight showed borderline evidence (aPR 1.23, 95% CI 0.99–1.53; p = 0.066). After multivariable adjustment, cumulative ART duration was not independently associated with prevalent hypertension (aPR per 1-year increase 1.00, 95% CI 0.99–1.02; p = 0.619) (Table 3). Table 3Adjusted prevalence ratios for independent factors associated with hypertension in multivariable Poisson regression modelsVariableCategoryaPR95% CIp-valueAge (years)Per 1-year increase1.021.01–1.030.002ART duration (years)Per 1-year increase1.000.99–1.020.619Marital statusMarried (ref)1.00––Single1.040.79–1.370.776Cohabiting0.980.70–1.380.929Divorced1.080.50–2.340.842Widowed1.000.79–1.270.980Education levelSecondary (ref)1.00––None1.150.84–1.570.378Primary1.060.85–1.330.594Higher1.010.70–1.460.962Employment statusEmployed (ref)1.00––Self-employed1.180.82–1.700.367Unemployed1.070.76–1.500.707Retired0.880.58–1.340.554Family history of hypertensionNo (ref)1.00––Yes2.832.25–3.57< 0.001BMI categoryNormal weight (ref)1.00––Obesity1.291.01–1.650.045Overweight1.230.99–1.530.066Salt/seasoning cube intakeNo (ref)1.00––Yes0.980.81–1.200.863Fruit and vegetable intakeTwice per week (ref)1.00––Once per week0.670.53–0.850.001Rarely0.760.56–1.040.083Three times per week0.680.44–1.040.077aPR adjusted prevalence ratio, CI confidence intervalThe ART-duration coefficient should be interpreted as an association conditional on current age and cardiometabolic factors, rather than as the total effect of cumulative ART exposure Adjusted prevalence ratios for independent factors associated with hypertension in multivariable Poisson regression models aPR adjusted prevalence ratio, CI confidence interval The ART-duration coefficient should be interpreted as an association conditional on current age and cardiometabolic factors, rather than as the total effect of cumulative ART exposure Sensitivity analyses addressing the relationship between current age and ART duration Because current age and cumulative ART duration are conceptually related, sensitivity models were fitted to clarify the interpretation of ART duration. The association between ART duration and hypertension was present in the crude model and in models adjusted only for current age or age at ART initiation. However, this association disappeared after adjustment for age and major clinical/metabolic covariates and in the final multivariable model, suggesting that current age and cardiometabolic factors explain a substantial part of the crude association between treatment duration and hypertension. Model overdispersion assessment Model overdispersion was assessed using the Pearson chi-square statistic. The Pearson chi-square was 248.17 with 440 degrees of freedom, corresponding to a dispersion ratio of 0.56 and p = 1.000. These results did not suggest overdispersion that would compromise the robust Poisson modelling approach. Restricted cubic spline analysis The restricted cubic spline analysis was revised to display the adjusted predicted probability of hypertension rather than an adjusted prevalence ratio. The model used logistic regression for visualization and adjusted for age, family history of hypertension, BMI category, and fruit and vegetable intake. There was no evidence of an overall association of ART duration (p = 0.709) or non-linearity (p = 0.576) (Fig. 1). Adjusted predicted probability of hypertension according to ART duration using restricted cubic splines. This Figure shows the adjusted predicted probability of hypertension across the observed range of ART duration using restricted cubic splines. The model was adjusted for age, family history of hypertension, BMI category, and fruit and vegetable intake. The solid line represents the adjusted predicted probability, and the shaded band represents the 95% confidence interval Summary of main analytical revisions The analysis was revised to improve interpretability of the ART-duration effect. The multivariable model retained age and ART duration because of their epidemiological relevance. Sensitivity analyses distinguished the crude association of ART duration from models adjusted for current age and from models using estimated age at ART initiation. Viral-load categories were simplified to avoid conceptual overlap between undetectable and suppressed viral-load categories. Dietary category labels were standardized, missing data were summarized, and the spline figure was revised to display predicted probability rather than an adjusted prevalence ratio. Discussion This cross-sectional study found that hypertension was common among adults living with HIV receiving ART in routine care at Yaounde Central Hospital. In the final adjusted model, older age, family history of hypertension, and obesity were independently associated with prevalent hypertension, whereas cumulative ART duration was not independently associated after adjustment for age and cardiometabolic factors. The observed prevalence of hypertension, 199/460 participants (43.3%), is clinically important and is consistent with the growing burden of cardiovascular comorbidity among PLHIV reported in Cameroon and elsewhere in sub-Saharan Africa [1–8]. These findings reinforce the importance of embedding cardiovascular risk detection and management within routine HIV care rather than treating hypertension as a separate, external condition. The attenuation of the crude association between ART duration and hypertension after adjustment should be interpreted carefully. Current age and cumulative ART duration are conceptually and statistically related in long-term HIV cohorts. Therefore, the coefficient for ART duration in the fully adjusted model does not represent the simple total association of longer time on ART. Rather, it reflects the association of ART duration conditional on current age and cardiometabolic factors. The null adjusted estimate should not be interpreted as evidence that ART exposure has no cardiometabolic relevance; instead, it indicates that cumulative ART duration was not independently associated with prevalent hypertension in this cross-sectional model and setting. The independent association between obesity and hypertension is consistent with the established role of adiposity in hypertension risk and is particularly important in the current era of long-term ART and increasing concern about weight gain after ART initiation or regimen switches [9–12]. Although this study did not evaluate specific antiretroviral drug classes or switches, the findings highlight the need for routine weight monitoring, lifestyle counselling, and early cardiovascular prevention in HIV services. Family history of hypertension showed the strongest independent association with prevalent hypertension. This finding emphasizes the importance of clinical risk stratification within HIV services. Asking about family history is simple, low-cost, and feasible in routine care, and may help identify patients who need more intensive blood-pressure monitoring and counselling. The dietary findings should be interpreted cautiously. Fruit and vegetable intake categories were associated with lower hypertension prevalence in some models, but the pattern was not strictly monotonic, the exposure was self-reported, and reverse causation is possible if participants with hypertension had already changed their diet. Similarly, the bivariable association for salt/seasoning cube intake disappeared after adjustment, suggesting possible exposure misclassification or residual confounding. The restricted cubic spline analysis did not provide evidence of an overall association or non-linear relationship between ART duration and adjusted predicted probability of hypertension. This supports the cautious interpretation that cumulative ART duration alone did not show an independent adjusted association with hypertension after accounting for age and cardiometabolic factors. From a programmatic perspective, the results support routine blood-pressure screening, weight management, lifestyle counselling, and structured hypertension care embedded within HIV services. This aligns with the rationale for integrated HIV-non-communicable disease care and with standardized primary-care approaches such as WHO HEARTS [13, 14]. In urban HIV clinics, particular attention should be paid to older adults, participants with obesity, and those reporting a family history of hypertension. Strengths and limitations This study has several strengths, including a clinical sample of 460 adults living with HIV, standardized blood-pressure assessment, use of prevalence ratios from robust Poisson regression for a common outcome, integration of sociodemographic, clinical, treatment-related, and behavioural variables, sensitivity analyses to clarify the interpretation of ART duration, a revised spline analysis, and improved reporting of missing data. The limitations are also important. First, the cross-sectional design precludes causal inference and is susceptible to reverse causation, especially for dietary and behavioural variables. Second, the outcome was prevalent hypertension rather than incident hypertension. Third, blood pressure was assessed at a cross-sectional visit, and some elevated values may represent transient elevation. Fourth, behavioural variables were self-reported and may be affected by recall or social desirability bias. Fifth, the study was conducted in a single urban HIV clinic with a predominance of women, limiting generalizability to men, rural populations, newly diagnosed patients, and people not retained in HIV services. Finally, detailed information on specific ART drug classes, historical treatment switches, and longitudinal weight change was not available for the present analysis. Conclusion Among adults living with HIV receiving ART in routine care in Yaounde, hypertension was frequent. In the final adjusted model, older age, family history of hypertension, and obesity were independently associated with prevalent hypertension, whereas cumulative ART duration was not independently associated after adjustment for age and cardiometabolic factors. These findings support the integration of routine blood-pressure screening, weight management, lifestyle counselling, and standardized hypertension management into HIV care services. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1. Acknowledgements We thank the staff of the Day Hospital of Yaounde Central Hospital and all participants who contributed to this study. Author contributions Francis Duhamel Nang Nang, André Pascal Kengne, Jean Pierre Junior Tchitetchoun, Charles Kouanfack, Simeon Pierre Choukem, and Anastase Dzudie conceived and designed the study. Francis Duhamel Nang Nang, Jean Pierre Junior Tchitetchoun, Paul Junior Chebo, Rita Marie Ifoue, François Anicet Onana Akoa, Lawson Ngwagwe Mbolueh, and Liliane Mfeukeu Kuate contributed to study implementation and data collection. Francis Duhamel Nang Nang, François Anicet Onana Akoa, and Luc Baudoin Fankoua TchapTcha performed the analyses and prepared the tables and figures. Francis Duhamel Nang Nang drafted the first version of the manuscript. Charles Kouanfack, Simeon Pierre Choukem, André Pascal Kengne, and Anastase Dzudie critically revised the manuscript for important intellectual content. All authors had access to the data, approved the final version, and agree to be accountable for all aspects of the work. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Data availability The individual participant data underlying the findings of this article (including text, tables, figures, and supplementary materials), accompanied by a detailed data dictionary, are the intellectual property of the research team. This data will be made available at reasonable requests to researchers whose proposals have been approved by the study’s principal investigators. The findings will be formally presented during the PhD thesis defense in Epidemiology at the University of Dschang. In addition, results have been communicated to the authorities of the Yaoundé Central Hospital, and key messages have been displayed in the Day Hospital unit as part of a preventive health initiative. Proposals should be directed to [francduhamelnang@yahoo.com](mailto: francduhamelnang@yahoo.com) . Access to the data will require the signing of a data use agreement. Declarations Ethics approval and consent to participate This study was approved by the Regional Ethics Committee for Human Health Research in the Centre Region of Cameroon (CRERSHC No. CEN000633/CRERSHC/2023) and authorized by the Director of Yaounde Central Hospital (No. 2023/265/AR/MINSANTE/SG/DHCY/UAF). Written informed consent was obtained from all participants. Participant confidentiality and anonymity were protected throughout the study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The individual participant data underlying the findings of this article (including text, tables, figures, and supplementary materials), accompanied by a detailed data dictionary, are the intellectual property of the research team. This data will be made available at reasonable requests to researchers whose proposals have been approved by the study’s principal investigators. The findings will be formally presented during the PhD thesis defense in Epidemiology at the University of Dschang. In addition, results have been communicated to the authorities of the Yaoundé Central Hospital, and key messages have been displayed in the Day Hospital unit as part of a preventive health initiative. Proposals should be directed to [francduhamelnang@yahoo.com](mailto: francduhamelnang@yahoo.com) . Access to the data will require the signing of a data use agreement.